MOLECULAR PARTNERS AG Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
MOLECULAR PARTNERS AG (MOLN) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of CHF 4.42 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2026-03-12
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|
| 2025-12-31 | 4.42M CHF 20-F · filed 2026-03-12 |
| 2024-12-31 | 4.11M CHF 20-F · filed 2026-03-12 |
| 2023-12-31 | 5.21M CHF 20-F · filed 2026-03-12 |